Oramed Pharmaceuticals

ORMPNASDAQ
$2.52
-0.0100-0.40%
Pre-Market: 4:09 PM EDT
15 minutes delayed

Oramed Pharmaceuticals (NASDAQ:ORMP) Stock, Guidance And Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

Get Alert
No data available to display

FAQ

Q

What is the most recent guidance for Oramed Pharmaceuticals (ORMP)?

A

There have been no specific sales or earnings guidance reported for Oramed Pharmaceuticals in recent months.

Browse guidance and forecast on all stocks.

People Also Watch